Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing
MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Showing 7 of 7 results